# OnCo record boundless-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/boundless-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "boundless-bio" ;
  schema:name "Boundless Bio"@en ;
  schema:description "Boundless Bio tried to treat cancers driven by extra loops of DNA outside the chromosomes, called ecDNA. Its lead drug did not show enough benefit in early trials, and in 2026 the company agreed to merge with a gene-editing company and leave cancer."@en ;
  schema:url <https://onco.cc/companies/boundless-bio/>, <https://boundlessbio.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://boundlessbio.com/>, <https://boundlessbio.com/what-we-do/>, <https://www.sec.gov/Archives/edgar/data/1782303/000119312524084736/d796750d8k.htm>, <https://www.sec.gov/Archives/edgar/data/1782303/000119312526278570/d159021dex991.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> .